Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association

Bozkurt, Biykem, Coats, Andrew J.S., Tsutsui, Hiroyuki, Abdelhamid, Ca Magdy, Adamopoulos, Stamatis, Albert, Nancy, Anker, Stefan D., Atherton, John +30 more·2021·European Journal of Heart Failure

Cited by (1,000)

Items 101–200 of 1,000

  1. Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
    Amy Hyein Kim, Jung Eun Jang, Jin Han · 2021 · Biomedicine & Pharmacotherapy
  2. Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
    Magnus Olof Wijkman, Brian Lee Claggett, Muthiah Vaduganathan, Jonathan W. Cunningham, Rasmus Rørth, Alice M. Jackson, Milton Packer, Michael R. Zile, Jean Lucien Rouleau, Karl B Swedberg et al. · 2022 · Cardiovascular Diabetology
  3. Effects of Exercise on Heart Failure with Preserved Ejection Fraction: An Updated Review of Literature
    Giulia Crisci, Mariarosaria De Luca, Roberta D’Assante, Brigida Ranieri, Anna Grazia D'Agostino, Valeria Valente, Federica Giardino, Valentina Capone, Salvatore Chianese, Salvatore Rega et al. · 2022 · Journal of Cardiovascular Development and Disease
  4. Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled Community Cohort
    Reza Mohebi, Dongyu Wang, Emily S. Lau, Juhi K. Parekh, Norrina B. Allen, Bruce M. Psaty, Emelia J. Benjamin, Daniel A Levy, Thomas J. Wang, Sanjiv Jayendra Shah et al. · 2023 · Journal of the American College of Cardiology
  5. Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien
    Susanne Rabady, Johann Altenberger, Markus Brose, Doris‐Maria Denk‐Linnert, Elisabeth Fertl, Florian Götzinger, Marı́a de la Cruz Pellı́n, Benedikt Hofbaur, Kathryn Hoffmann, Renate Hoffmann-Dorninger et al. · 2021 · Wiener klinische Wochenschrift
  6. Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of literature and meta-analysis
    Martin Rebolledo‐Del Toro, Nancy Herrera-Leaño, Julian Esteban Barahona Correa, Óscar Múñoz, Daniel Gerardo Fernández-Ávila, Ángel Alberto García Peña · 2023 · Heart Failure Reviews
  7. Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity?
    Paolo Severino, Andrea D’Amato, Silvia Prosperi, Alessandra Dei, Anna Vittoria Mattioli, Antonio Cevese, Giuseppina Novo, María Prat, Roberto Pedrinelli, Riccardo Raddino et al. · 2022 · Journal of Clinical Medicine
  8. The importance of timing in postcardiotomy venoarterial extracorporeal membrane oxygenation: A descriptive multicenter observational study
    Silvia Mariani, I‐Wen Wang, Bas C. T. van Bussel, Samuel Heuts, Dominik Wiedemann, Diyar Saeed, Iwan C.C. van der Horst, Mattéo Pozzi, Antonio Loforte, Udo Boeken et al. · 2023 · Journal of Thoracic and Cardiovascular Surgery
  9. Management of Heart Failure With Improved Ejection Fraction
    Nandan Kodur, W.H. Wilson Tang · 2025 · JACC Heart Failure
  10. A Meta-Analysis of Growth Differentiation Factor-15 and Prognosis in Chronic Heart Failure
    Jinwen Luo, Wenhui Duan, Lei Song, Yanqiao Yu, Dazhuo Shi · 2021 · Frontiers in Cardiovascular Medicine
  11. Heart Failure and Obesity
    Just Dronkers, Dirk Jan van Veldhuisen, Peter van der Meer, Laura M G Meems · 2024 · Journal of the American College of Cardiology
  12. Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study
    Chris P Gale, John Robert Hurst, Nathaniel Mark Hawkins, Jean Bourbeau, MeiLan King Han, Carolyn S.P. Lam, Darcy D. Marciniuk, David Price, Daiana Stolz, Ty J. Gluckman et al. · 2025 · European Journal of Preventive Cardiology
  13. Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction
    Christian Basile, Felix Lindberg, Lina Benson, Federica Guidetti, Ulf Dahlström, Massimo Francesco Piepoli, Peter G. M. Mol, R Scorza, Aldo Pietro Maggioni, Lars H. Lund et al. · 2025 · Circulation
  14. Left ventricular ejection fraction as the primary heart failure phenotyping parameter
    Lars H. Lund, Bertram Pitt, Marco Metra · 2022 · European Journal of Heart Failure
  15. Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post–hospital discharge period
    J. Butler, M. Petrie, M. Bains, Tracy Bawtinheimer, Jillianne R. Code, Teresa Levitch, E. Malvolti, P. Monteleone, Petrina Stevens, Jenny Vafeiadou et al. · 2023 · Research Involvement and Engagement
  16. Heart Failure Improvement, Remission, and Recovery: A European Journal of Heart Failure Expert Consensus Document
    Jean‐Sébastien Hulot, Jozine M. ter Maaten, Antoni Bayés‐Genís, Brian P. Halliday, Marco Metra, Brenda Moura, Mark Colquhoun Petrie, Gianluigi Savarese, Michele Senni, Sophie Van Linhout et al. · 2025 · European Journal of Heart Failure
  17. The year in cardiovascular medicine 2021: heart failure and cardiomyopathies
    Johann K Bauersachs, Rudolf A. de Boer, JoAnn M. Lindenfeld, Biykem Bozkurt · 2021 · European Heart Journal
  18. Prevalence and Predictors of Sleep-Disordered Breathing in Chronic Heart Failure: The SchlaHF-XT Registry
    Michael E. Arzt, Olaf Oldenburg, Andrea Graml, Jürgen Schnepf, Erland Erdmann, Helmut Teschler, Christoph Schoebel, Holger Woehrle, the SchlaHF-XT investigators · 2022 · ESC Heart Failure
  19. The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?
    Kieran F. Docherty, Antoni Bayés‐Genís, Javed Butler, Andrew J.S. Coats, Mark H. Drazner, Emer Joyce, Carolyn S.P. Lam · 2022 · European Heart Journal Supplements
  20. Global, regional, and national burdens of heart failure in adolescents and young adults aged 10–24 years from 1990 to 2021: an analysis of data from the Global Burden of Disease Study 2021
    Chengzhi Yang, Yuhe Jia, Changlin Zhang, Zening Jin, Yue Ma, Xuanye Bi, Aiju Tian · 2024 · EClinicalMedicine
  21. Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients
    Patrick Barry Mark, Kenneth Mangion, Alastair J. Rankin, Elaine Rutherford, Ninian N. Lang, Mark Colquhoun Petrie, Sokratis Stoumpos, Rajan Kantilal Patel · 2022 · Clinical Kidney Journal
  22. Inflammatory and Cardiac Biomarkers in Relation with Post-Acute COVID-19 and Mortality: What We Know after Successive Pandemic Waves
    Lionte, Catalina, Sorodoc, Victorita, Haliga, Raluca Ecaterina, Bologa, Cristina, Ceasovschih, Alexandr, Petris, Ovidiu Rusalim, Coman, Adorata Elena, Stoica, Alexandra, Sirbu, Oana, Puha, Gabriela et al. · 2022 · Diagnostics
  23. Association between fibrinogen‐to‐albumin ratio and prognosis of patients with heart failure
    Qianqian Xu, Chenxi Zhu, Qianqian Zhang, Zesong Hu, Kangting Ji, Qian Lu · 2023 · European Journal of Clinical Investigation
  24. Advances in management of heart failure
    Paul A. Heidenreich, Alexander T. Sandhu · 2024 · BMJ
  25. Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
    H. Al-kuraishy, G. Sulaiman, H. A. Mohammed, Sohaib G. Mohammed, A. Al-Gareeb, Ali K. Albuhadily, Retaj A. Dawood, A. Al Ali, Mohammed H. Abu-Alghayth · 2025 · Frontiers in Medicine
  26. In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
    Zachary L. Cox, Shuktika Nandkeolyar, Andrew J Johnson, JoAnn M. Lindenfeld, Aniket S. Rali · 2022 · Cardiac failure review
  27. Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
    Vincenzo Castiglione, Francesco Gentile, Nicolò Ghionzoli, Martina Chiriacò, Giorgia Panichella, Alberto Aimo, Giuseppe Vergaro, Alberto Giannoni, Claudio Passino, Michele Emdin · 2023 · Cardiac failure review
  28. Heart failure with reduced ejection fraction
    Antonio Nicola Cannata, Maria Generosa Crespo-Leiro, Daniel I. Bromage, Frank Ruschitzka, Theresa A. McDonagh · 2025 · The Lancet
  29. Circulating Levels and Prognostic Cut-Offs of sST2, hs-cTnT, and NT-proBNP in Women vs. Men with Chronic Heart Failure
    Giuseppe Vergaro, Francesco Gentile, Alberto Aimo, James L. Januzzi, Mark Richards, Carolyn S.P. Lam, Rudolf A. de Boer, Laura M.G. Meems, Roberto Latini, Lidia Irene Staszewsky et al. · 2022 · ESC Heart Failure
  30. Heart Failure During the COVID-19 Pandemic: Clinical, Diagnostic, Management, and Organizational Dilemmas
    Alberto Palazzuoli, Marco Metra, Sean P. Collins, Marianna Adamo, Andrew P. Ambrosy, Elena‐Laura Antohi, Tuvia Ben Gal, Dimitrios T. Farmakis, Finn Gustafsson, Loreena Hill et al. · 2022 · ESC Heart Failure
  31. Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis
    Hooman Bakhshi, Sam A. Michelhaugh, Scott A. Bruce, Stephen L. Seliger, Xiaoxiao Qian, Bharath Ambale‐Venkatesh, Vinithra Varadarajan, Pramita Bagchi, João A.C. Lima, Christopher R. deFilippi · 2023 · EBioMedicine
  32. Deep Phenotype Characterization of Hypertensive Response to Exercise: Implications on Functional Capacity and Prognosis Across the Heart Failure Spectrum
    Nicola Riccardo Pugliese, Nicolò De Biase, Lavinia Del Punta, Alessio Balletti, Silvia Armenia, Simona Buralli, Alessandro Mengozzi, Stefano Taddei, Marco Metra, Matteo Pagnesi et al. · 2023 · European Journal of Heart Failure
  33. Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review
    Robert John Mentz, Stephen Brunton, Janani Rangaswami · 2023 · Cardiovascular Diabetology
  34. Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
    Joost Boeckmans, Jürgen H. Prochaska, Alexander Gieswinkel, Michael Böhm, Philipp Sebastian Wild, Jörn Markus Schattenberg · 2024 · The Lancet Regional Health - Europe
  35. Short-Chain Fatty Acids and Their Metabolic Interactions in Heart Failure
    Laura Chulenbayeva, Argul Issilbayeva, Aliya Sailybayeva, Makhabbat S. Bekbossynova, Samat Kozhakhmetov, Almagul R. Kushugulova · 2025 · Biomedicines
  36. Acute Heart Failure Is a Malignant Process: But We Can Induce Remission
    Gad Cotter, Beth A. Davison, Carolyn S.P. Lam, Marco Metra, Piotr P. Ponikowski, John R. Teerlink, Alexandre Mebazaa · 2023 · Journal of the American Heart Association
  37. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies
    Anuradha Lala, CARINE E. HAMO, Biykem Bozkurt, Mona Fiuzat, Vanessa L. Blumer, Daniel Bukhoff, Javed Butler, Maria Rosa Costanzo, Gary Michael Felker, Gerasimos S Filippatos et al. · 2023 · JACC Heart Failure
  38. Safety of Continuing Mineralocorticoid Receptor Antagonist Treatment in Patients with Heart Failure with Reduced Ejection Fraction and Severe Kidney Disease: Data from Swedish Heart Failure Registry
    Federica Guidetti, Lars H. Lund, Lina Benson, Camilla Hage, Francesca Musella, Davide Stolfo, Peter G. M. Mol, Andreas J. Flammer, Frank Thomas Ruschitzka, Ulf Dahlström et al. · 2023 · European Journal of Heart Failure
  39. Targeting estrogen receptor signaling for treating heart failure
    Chenyue Qian, Jing-Jin Liu, Hua-Dong Liu · 2023 · Heart Failure Reviews
  40. The global epidemiology of heart failure: a comprehensive and contemporary review
    Valeria Valente, Renzo Laborante, Amr M. Abdin, Peter Moritz Becher, M L Mitja Lainscak, Marija M. Polovina, Cristina Gavina, Gianluigi Savarese · 2026 · European Journal of Heart Failure
  41. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes
    Ana Maria Stanton, Muthiah Vaduganathan, Lee‐Shing Chang, Alexander Turchin, James L. Januzzi, Vanita R. Aroda · 2021 · Current Diabetes Reports
  42. Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction
    Kangkang Su, Mingquan Li, Lili Wang, Shipeng Tian, Jingjing Su, Jian Gu, Shuxia Chen · 2022 · International Journal of Cardiology
  43. Extracellular Non-Coding RNAs in Cardiovascular Diseases
    Zeyidan Jiapaer, Chengyu Li, Xinyu Yang, Lingfei Sun, Emeli Chatterjee, Lingying Zhang, Ji Lei, Guoping Li · 2023 · Pharmaceutics
  44. Effectiveness of tirzepatide in patients with HFpEF using a target trial emulation retrospective cohort study
    Yu‐Min Lin, Kuang‐Ming Liao, Tsung Yu, Jheng‐Yan Wu, Chih‐Cheng Lai · 2025 · Nature Communications
  45. HFpEF and MASLD: converging mechanisms and clinical implications
    Federico Capone, Steffen P. Häseli, Luo Liu, Stefano Strocchi, Claudia Langenberg, Aldons Jake Lusis, Maik Pietzner, Deborah M. Muoio, Oliver J. Rider, Betty Raman et al. · 2026 · Nature Reviews Cardiology
  46. CircHIPK3 Plays Vital Roles in Cardiovascular Disease
    Lei Zhang, Yin Wang, Fei Yu, Xin Li, Huijuan Gao, Peifeng Li · 2021 · Frontiers in Cardiovascular Medicine
  47. Outcomes and Predictors of Mortality Among Cardiac Intensive Care Unit Patients With Heart Failure
    Jacob Colin Jentzer, Yogesh N.V. Reddy, Andrew N. Rosenbaum, Shannon M. Dunlay, Barry A. Borlaug, Steven M. Hollenberg · 2022 · Journal of Cardiac Failure
  48. Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
    Paolo Morfino, Alberto Aimo, Vincenzo Castiglione, Giuseppe Vergaro, Michele Emdin, Aldo Clerico · 2022 · Journal of Cardiovascular Development and Disease
  49. Empagliflozin: A Review in Symptomatic Chronic Heart Failure
    James E. Frampton · 2022 · Drugs
  50. Heart Failure With Preserved Ejection Fraction in the Elderly Population: Basic Mechanisms and Clinical Considerations
    Kimia Gharagozloo, Mozhdeh Mehdizadeh, George A. Heckman, Robert Alan Rose, Jonathan G. Howlett, Susan E. Howlett, Stanley Nattel · 2024 · Canadian Journal of Cardiology
  51. Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
    Toru Kondo, Ross T. Campbell, Pardeep S. Jhund, Inder S. Anand, Peter E. Carson, Carolyn S.P. Lam, Sanjiv Jayendra Shah, Muthiah Vaduganathan, Faiez M. Zannad, Michael R. Zile et al. · 2024 · JACC Heart Failure
  52. Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure
    Barbora Judita Kasperová, Miloš Mráz, Petr Svoboda, Daniel Hlaváček, Helena Kratochvílová, István Módos, Nikola Vrzáčková, Peter Ivák, Petra Janovská, Tatyana Kobets et al. · 2024 · Cardiovascular Diabetology
  53. Long-Term Follow-Up of the TRED-HF Trial: Implications for Therapy in Patients with Dilated Cardiomyopathy and Heart Failure Remission
    L Cheng, Daniel J. Hammersley, Aaraby Ragavan, Saad Javed, Srinjay Mukhopadhyay, John Gregson, Jennie Han, Zohya Khalique, Amrit S. Lota, Antonis A. Pantazis et al. · 2024 · European Journal of Heart Failure
  54. RhoA rescues cardiac senescence by regulating Parkin-mediated mitophagy
    Joanne Ern Chi Soh, Akio Shimizu, Md Rasel Molla, Dimitar P. Zankov, Le Kim Chi Nguyen, Mahbubur Rahman Khan, Wondwossen Wale Tesega, Si Chen, Misa Tojo, Yoshito Ito et al. · 2023 · Journal of Biological Chemistry
  55. SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established
    Adam Kia Shooshtarian, Kevin O’Gallagher, Ajay M. Shah, Min Zhang · 2025 · Heart Failure Reviews
  56. The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure
    Simone Pasquale Crispino, Andrea Segreti, Vincenzo Nafisio, Daniele Valente, Filippo Crisci, Aurora Ferro, Ilaria Cavallari, Annunziata Nusca, Gian Paolo Ussia, Francesco Grigioni · 2025 · Biomedicines
  57. Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
    Suleman Aktaa, Gorav Batra, John G.F. Cleland, Andrew J.S. Coats, Lars H. Lund, Theresa A. McDonagh, Giuseppe M.C. Rosano, Petar M Seferovic, Peter Vaško, Lars C. Wallentin et al. · 2022 · European Heart Journal
  58. Head‐to‐head comparison between recommendations by the ESC and ACC / AHA / HFSA heart failure guidelines
    Antoni Bayés‐Genís, Alberto Aimo, Marco Metra, Stefan D. Anker, Petar M Seferovic, Claudio Rapezzi, Vincenzo Castiglione, Julio E. Núñez, Michele Emdin, Giuseppe M.C. Rosano et al. · 2022 · European Journal of Heart Failure
  59. Matching of O2 Utilization and O2 Delivery in Contracting Skeletal Muscle in Health, Aging, and Heart Failure
    Michael Nyberg, ANDREW MARK JONES · 2022 · Frontiers in Physiology
  60. Imaging of heart disease in women: review and case presentation
    Nidaa Mikaïl, Alexia Rossi, Susan Bengs, Ahmed Haider, Barbara Elisabeth Stähli, Angela Portmann, Alessio Impériale, Valérie Treyer, Alexander Meisel, Aju Paul Pazhenkottil et al. · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
  61. Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function
    Trejeeve Martyn, Joshua Saef, Anusha Ray Dey, Rola Khedraki, Vardhmaan Jain, Patrick H. Collier, Wael A. Jaber, Jerry D. Estep, Mazen A Hanna, W.H. Wilson Tang · 2022 · JACC Heart Failure
  62. Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence
    Francesç Formiga, Julio E. Núñez, María José Castillo Moraga, Marta Cobo Marcos, M.I. Egocheaga, Concha F. García‐Prieto, Ángel Trueba-Sáiz, Arantxa Matalí Gilarranz, José María Fernández Rodríguez · 2023 · Heart Failure Reviews
  63. Cognitive Impairment and Synaptic Dysfunction in Cardiovascular Disorders: The New Frontiers of the Heart–Brain Axis
    Teresa Soda, Teresa Pasqua, Giovambattista De Sarro, Francesco Domenico Moccia · 2024 · Biomedicines
  64. Finerenone in Heart Failure With Improved Ejection Fraction
    Maria A. Pabón, Orly Vardeny, Muthiah Vaduganathan, Akshay Suvas Desai, Brian Lee Claggett, Ian J. Kulac, Pardeep S. Jhund, Carolyn S.P. Lam, Michele Senni, Sanjiv Jayendra Shah et al. · 2025 · JAMA Cardiology
  65. Heart Failure With Improved Ejection Fraction
    Mauro Riccardi, Maria A. Pabón, Ankeet S. Bhatt, Gianluigi Savarese, Marco Metra, Maurizio Volterrani, Carlo Lombardi, Muthiah Vaduganathan, Scott David Solomon, Orly Vardeny et al. · 2025 · Journal of the American College of Cardiology
  66. Phenotypes of Cardiovascular Diseases: Current Status and Future Perspectives
    Hang Zhang, Xiumeng Hua, Jiangping Song · 2021 · Phenomics
  67. New Insights Into the Role of Inflammation in the Brain in Heart Failure
    Emilio Badoer · 2022 · Frontiers in Physiology
  68. Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction
    Brent Gudenkauf, Gabriel E. Shaya, Monica Mukherjee, Erin D. Michos, José Madrazo, Lena M. Mathews, Sanjiv Jayendra Shah, Kavita Sharma, Allison G. Hays · 2023 · Journal of Cardiology
  69. Right Side of the Heart Pulmonary Circulation Unit Involvement in Left-Sided Heart Failure
    Alberto Maria Marra, Alexander E. Sherman, Andrea Salzano, Marco Guazzi, Rajan Saggar, Iain B Squire, Antonio Cittadini, Richard N. Channick, Eduardo Bossone · 2021 · CHEST Journal
  70. Patients With Bicuspid Aortic Stenosis Demonstrate Adverse Left Ventricular Remodeling and Impaired Cardiac Function Before Surgery With Increased Risk of Postoperative Heart Failure
    Johan O. Wedin, Ola Vedin, Sergey Rodin, Oscar E. Simonson, Jonathan Hörsne Malmborg, Johan Pallin, Stefan Karl James, Frank Arnold Flachskampf, Elisabeth Ståhle, Karl‐Henrik Grinnemo · 2022 · Circulation
  71. Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012–15
    Anping Cai, Congyi Zheng, Jiayuan Qiu, Gregg C. Fonarow, Gregory Y.H. Lip, Yingqing Feng, Zengwu Wang · 2023 · European Journal of Preventive Cardiology
  72. Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF Study
    Antonio Ruiz‐García, Adalberto Serrano-Cumplido, Carlos Escobar, Ezequiel Arranz-Martínez, Miguel Turégano-Yedro, Vicente Pallarés‐Carratalá · 2023 · Journal of Clinical Medicine
  73. Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of 32 randomized trials
    Konstantinos Pamporis, Paschalis Karakasis, Μarios Sagris, Ippokratis Zarifis, Konstantinos I. Bougioukas, Eirini Pagkalidou, Nikias Milaras, Athanasios Samaras, Panagiotis Theofilis, Nikolaos Fragakis et al. · 2024 · Current Problems in Cardiology
  74. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
    GBD Collaborators, Gregory A. Roth · 2025 · SSRN Electronic Journal
  75. Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
    Granberg, Kenneth L., Sakamaki, Shigeki, Larsson, Niklas, Bergström, Fredrik, Fuchigami, Ryuichi, Niwa, Yasuki, Ryberg, Erik, Backmark, Anna, Kato, Harutoshi, Miyazaki, Shiki et al. · 2024 · Journal of Medicinal Chemistry
  76. Insights into the European Heart Failure Epidemiology
    Petar M Seferovic, Marija M. Polovina, Gianluigi Savarese, Ivan Milinković, Dejana M. Stanisavljevic, Lars H. Lund, Ovidiu Chioncel, Magdy Abdelhamid, Yu. M. Lopatin, Stefan Störk et al. · 2025 · European Journal of Heart Failure
  77. The spectrum of comorbidities at the initial diagnosis of heart failure a case control study
    Sven Heiko Loosen, Christoph Roderburg, Ole Curth, Julia Gänsbacher, Markus Sebastian Jördens, Tom Luedde, Marcel Konrad, Karel Kostev, Mark Luedde · 2022 · Scientific Reports
  78. Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure
    Anzhu Wang, Wei Zhao, Kaituo Yan, Pingping Huang, Hongwei Zhang, Zhibo Zhang, Dawu Zhang, Xiaochang Ma · 2022 · Frontiers in Pharmacology
  79. Dapagliflozin reduces risk of heart failure rehospitalization in diabetic acute myocardial infarction patients: a propensity score-matched analysis
    Lipeng Mao, Dabei Cai, Boyu Chi, Tingting Xiao, Ailin Zou, Yu Wang, Qianwen Chen, Qingqing Gu, Qingjie Wang, Yuan Ji et al. · 2023 · European Journal of Clinical Pharmacology
  80. Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT‐CHF (European) study with the ASIAN‐HF registry
    Thong Huy Cao, Wan Ting Tay, Donald J. L. Jones, John G.F. Cleland, Jasper Tromp, Johanna Elisabeth Emmens, Tiew‐Hwa Katherine Teng, Chanchal Chandramouli, Oliver C. Slingsby, Stefan D. Anker et al. · 2024 · European Journal of Heart Failure
  81. State of Precision Medicine for Heart Failure with Preserved Ejection Fraction in a New Therapeutic Age
    Roy R. Rasalam, Andrew Paul Sindone, Gary Deed, Ralph G. Audehm, John James Atherton · 2025 · ESC Heart Failure
  82. Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?
    Qing Zhou, Peixin Li, Hengli Zhao, Xingbo Xu, Shaoping Li, Jing Zhao, Dingli Xu, Qingchun Zeng · 2021 · Frontiers in Cardiovascular Medicine
  83. A multi-scale and multi-domain heart sound feature-based machine learning model for ACC/AHA heart failure stage classification
    Yineng Zheng, Xingming Guo, Yingying Wang, Jian Qin, Fajin Lv · 2022 · Physiological Measurement
  84. Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides
    Susana Ravassa, Josep Lupón, Begoña López, Pau Codina, Mar Domingo, Elena Revuelta‐López, María U. Moreno, Gorka San José, Evelyn Santiago‐Vacas, Germán Cediel et al. · 2022 · JACC Heart Failure
  85. Can Extracellular Vesicles as Drug Delivery Systems Be a Game Changer in Cardiac Disease?
    Akihiko Okamura, Yusuke Yoshioka, Yoshihiko Saito, Takahiro Ochiya · 2022 · Pharmaceutical Research
  86. Sex differences in long-term heart failure prognosis: a comprehensive meta-analysis
    Weida Qiu, Wenbin Wang, Shiping Wu, Yanchen Zhu, He Zheng, Yingqing Feng · 2024 · European Journal of Preventive Cardiology
  87. Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta‐analysis
    Lucas Lauder, Tiago Pereira, Markus Christoph Degenhardt, Sebastian Ewen, Saarraaken Kulenthiran, Andrew J.S. Coats, Michael Böhm, Stefan D. Anker, Bruno R. da Costa, Felix Mahfoud · 2021 · European Journal of Heart Failure
  88. The Right Heart in Patients with Cancer. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
    Kalliopi Keramida, Dimitrios T. Farmakis, Amina Rakisheva, Carlo Gabriele Tocchetti, Pietro Ameri, Riccardo Asteggiano, Ana Barac, Jeroen Joost Bax, Antoni Bayés‐Genís, Jutta K Bergler-Klein et al. · 2024 · European Journal of Heart Failure
  89. Long-Term Exposure to Fine Particulate Matter Constituents, Genetic Susceptibility, and Incident Heart Failure Among 411 807 Adults
    Feipeng Cui, Lei Zheng, Jing Zhang, Linxi Tang, Yudiyang Ma, Dankang Li, Jianing Wang, Meiqi Xing, Junqing Xie, Jian Yang et al. · 2024 · European Journal of Heart Failure
  90. Lycopene inhibits doxorubicin-induced heart failure by inhibiting ferroptosis through the Nrf2 signaling pathway
    Rong Ying Huang, Chao Zhou, Tianxiang Wang, Yuanli Chen, Zhouling Xie, Lingling Wei, Yajun Duan, Chenzhong Liao, Chuanrui Ma, Xiaoxiao Yang · 2025 · Life Sciences
  91. Heart Failure in Older Patients: An Update
    Massimo Montalto, Federica D’Ignazio, Sara Camilli, Silvino Di Francesco, Marco Fedele, Francesco Landi, Antonella Gallo · 2025 · Journal of Clinical Medicine
  92. Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction
    Nassiba Menghoum, Maria Chiara Badii, Martin Leroy, Marie Parra, Clotilde Roy, Sibille Lejeune, David Vancraeynest, Agnès Pasquet, Dulce A. Brito, Barbara Casadei et al. · 2025 · Cardiovascular Diabetology
  93. Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024)
    Irina Evgen'evna Chazova, Чихладзе Новелла Михайловна, Nataliya V. Blinova, Аксенова Анна Владимировна, Tatiana A. Alekseeva, Lali G. Ambatiello, Yu. А. Balanova, Anna E. Bragina, Nikolai M. Danilov, O. M. Drapkina et al. · 2024 · Systemic Hypertension
  94. Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity
    Veronika Boichenko, Victoria Maria Noakes, Benedict Reilly-O’Donnell, Giovanni Battista Luciani, Costanza Emanueli, Fabio Martelli, Julia Gorelik · 2025 · Cells
  95. Large animal models of heart failure with preserved ejection fraction
    Chihiro Miyagi, Takuma Miyamoto, Taiyo Kuroda, Jamshid H. Karimov, Randall C. Starling, Kiyotaka Fukamachi · 2021 · Heart Failure Reviews
  96. Therapeutic implications of targeting pyroptosis in Cardiac-related etiology of heart failure
    Olive Habimana, Oluwabukunmi Modupe Salami, Jinfu Peng, Guanghui Yi · 2022 · Biochemical Pharmacology
  97. Sequencing and Titrating Approach of Therapy in Heart Failure with Reduced Ejection Fraction Following the 2021 European Society of Cardiology Guidelines: An International Cardiology Survey
    Charles Fauvel, Guillaume Bonnet, Wilfried Müllens, Clara Inés Saldarriaga Giraldo, Anja Zupan Mežnar, Anders L Barasa, Mariya Petkova Tokmakova, Anastasia Shchendrygina, Francisco Moscoso Costa, Massimo Mapelli et al. · 2022 · European Journal of Heart Failure
  98. Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis
    James P. Curtain, Matthew M.Y. Lee, John J.V. McMurray, Roy S. Gardner, Mark Colquhoun Petrie, Pardeep S. Jhund · 2022 · Heart
  99. Optimizing Outcomes in Heart Failure: 2022 and Beyond
    Ewa Anita Jankowska, Tomas Andersson, Claudia Kaiser‐Albers, Biykem Bozkurt, Ovidiu Dragomir Chioncel, Andrew J.S. Coats, Loreena Hill, Friedrich Koehler, Lars H. Lund, Theresa A. McDonagh et al. · 2023 · ESC Heart Failure
  100. Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society
    Andrea M. Yeung, Jingtong Kaya Huang, Ambarish Pandey, Ibrahim A. Hashim, David E. Kerr, Rodica Pop‐Busui, Connie M. Rhee, Viral N. Shah, Lia Bally, Antoni Bayés‐Genís et al. · 2023 · Progress in Cardiovascular Diseases